ZstatFlu®-II test: A chemiluminescent neuraminidase assay for influenza viral diagnostics

Luminescence

Volumn 18, Issue 3, 2003, Pages 131-139

  Achyuthan, Komandoor E ^a   Pence, Lisa M ^b,c   Appleman, James R ^b,d   Shimasaki, Craig D ^b  

^a QTL Biosystems   (United States)

^b ZymeTx Incorporated   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

1,2 dioxetane 4,7 dimethoxy Neu5Ac; Chemiluminescence; Diagnosis; Influenza; Neuraminidase; Stability

Indexed keywords

ENZYMATIC HYDROLYSIS;

1,2-DIOXETANE-4,7-DIMETHOXY-NEU5AC; DIAGNOSTIC TESTS; DIOXETANES; ENZYMATIC REACTION; INFLUENZA; N ACETYLS; NEURAMINIDASE; NEUTRAL PH; POINT OF CARE; SPECIFIC SUBSTRATES;

CHEMILUMINESCENCE;

CARBOXYL GROUP; NEURAMINIC ACID DERIVATIVE; SIALIDASE; SPIROADAMANTYL 1,2 DIOXETANE 4,7 DIMETHOXY N ACETYLNEURAMINIC ACID; UNCLASSIFIED DRUG; VIRUS ENZYME; 1,2 DIOXETANE; 1,2-DIOXETANE; HETEROCYCLIC COMPOUND; SODIUM HYDROXIDE;

ACIDITY; ARTICLE; CATALYSIS; CHEMOLUMINESCENCE; ENZYME SUBSTRATE; HYDROLYSIS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LABORATORY TEST; PH; ANALYTICAL EQUIPMENT; CHEMISTRY; ENZYME SPECIFICITY; ENZYMOLOGY; HUMAN; INFLUENZA; INSTRUMENTATION; ISOLATION AND PURIFICATION; KINETICS; METHODOLOGY; NOSE MUCOSA; PHARYNX; SENSITIVITY AND SPECIFICITY; TEMPERATURE; VIROLOGY;

CHEMILUMINESCENT MEASUREMENTS; HETEROCYCLIC COMPOUNDS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; KINETICS; NASAL MUCOSA; NEURAMINIDASE; PHARYNX; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SODIUM HYDROXIDE; SUBSTRATE SPECIFICITY; TEMPERATURE; VIROLOGY;

EID: 1542787846     PISSN: 15227235     EISSN: 10991271     Source Type: Journal    
DOI: 10.1002/bio.714     Document Type: Article

References (30)

1. Laver G and Carman E. The origin and control of pandemic influenza. Science 2001; 293: 1776-1777.
2. Williams JP and Leadnar W. New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizations. Am. J. Manag. Care 2002; 8: S143-154.
3. Taubenberger JK and Layne SP. Diagnosis of influenza virus: coming to grips with the molecular era. Mol. Diagn. 2001; 6: 291-305.
4. Govaert THME, Dinant GJ and Knottnerus AK. The predictive value of influenza symptomatology in elderly people. Fam. Pract. 1998; 15: 16-22.
5. Shimasaki CD, Achyuthan KE, Hansjergen JA and Appleman JR. Rapid diagnostics: the detection of neuraminidase activity as a technology for high-specificity targets. Phil. Trans. R. Soc. B. 2001; 356: 1925-1931.
6. Griffin AD, Perry AS and Fleming DM. Cost-effectiveness analysis of inhaled zanamvir in the treatment of influenza A and B in high-risk patients. Pharmacoeconomics 2001; 19: 293-301.
7. Peters PH, Gravenstein S and Norwood P et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J. Am. Geriatr. Soc. 2001; 49: 1025-1031.
8. Hamilton MS, Abel DM and Ballam YJ et al. Clinical evaluation of the ZstatFlu®-II test: a chemiluminescent rapid diagnostic test for influenza. J. Clin. Microbiol. 2002; 40: 2331-2334.
9. Liolios L, Jenney A, Spelman D, Kotsimbos T, Catton M and Wesselingh S. Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens. J. Clin. Microbiol. 2001; 39: 2779-2783.
10. Shimizu H, Watanabe S and Kawakami C et al. Sensitivity and specificity of rapid diagnosis kit detecting separately influenza A and B viruses. Kansenshogaku Zasshi 2000; 74: 1038-1043.
11. Tucker SP, Cox C and Steaffens J. A flu optical immunoassay (ThermoBioStar's Flu OIA): a diagnostic tool for improved influenza management. Phil. Trans. R. Soc. B. 2001; 356: 1915-1924.
12. Kawakami C, Shimizu H and Watanabe S et al. Evaluation of immunochromatography method for rapid detection of influenza A and B viruses. Kansenshogaku Zasshi 2001; 75: 792-799.
13. Liav A, Hansjergen JA, Achyuthan KE and Shimasaki CD. Synthesis of bromoindolyl-4,7-di-O-methyl-Neu5Ac: specificity toward influenza A and B viruses. Carbohydrate Res. 1999; 317: 198-203.
14. Achyuthan KE and Achyuthan AM. Comparative enzymology, biochemistry and pathophysiology of human exo-α-sialidases (neuraminidases). Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 2001; 129: 29-64.
15. Wiedbrauk DL. 'Rapid influenza tests: what works?'. 17th Annual Clinical Virology Symposium, Clearwater, FL Symposium: Proceedings, 2001; pp 107-123.
16. Kricka LJ. Application of bioluminescence and chemiluminescence in biomedical sciences. Methods Enzymol. 2000; 305: 333-345.
17. Kricka LJ, Voyta JC and Bronstein I. Chemiluminescent methods for detecting and quantitating enzyme activity. Methods Enzymol. 2000; 305: 370-390.
18. Buxton RC, Edwards B, Juo RR, Voyta JC, Tisdale M and Bethell RC. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamvir. Anal. Biochem. 2000; 280: 291-300.
19. Achyuthan KE. Enzymatic and kinetic properties of blood coagulation factor XIIIa and guinea pig liver transglutaminase utilizing (6-[N-(4-aminobutyl)-N-ethylamino]-2,3-dihydrophthalazine-1,4-dione, as a novel, specific and sensitive chemiluminescent substrate. J. Biolumin. Chemilumin. 1998; 13: 1-11.
20. Achyuthan KE, Pence LM and Mantell DR et al. Engineering a chemical implementation device and an imaging device for detecting chemiluminescence with a Polaroid™ High Speed Detector Film: application to influenza diagnostics with the ZstatFlu®-II test. Luminescence 2003; 18: 79-89.
21. Yamada A and Imanishi J. Detection of influenza B virus in throat swabs using the polymerase chain reaction. Acta Virol. 1992; 36: 320-325.
22. Achyuthan KE. Enhancement of aminophthalhydrazides chemiluminescence by N-β-alanyl-L-histidine (L-carnosine). Luminescence 1999; 14: 75-81.
23. Achyuthan KE. Low-level chemiluminescence of N-β-alanyl-L-histidine (L-carnosine). Luminescence 1999; 14: 245-253.
24. Achyuthan KE. Thiols enhance the sensitivity of luminescent assays for non-cross-linked and covalently cross-linked aminophthalhydrazides. Luminescence 2001; 16: 257-262.
25. Voyta JC, Edwards B, Bronstein I and McGrath P. Chemiluminescent enhancement of enzyme-activated decomposition of enzymatically cleavable chemiluminescent 1,2-dioxetanes. US Patent 1992; No. 5,145,772.
26. Bronstein II, Edwards B and Voyta JC. Enhancement of chemiluminescent assays. US Patent 1996; No. 5,547,836.
27. Capon B. Intramolecular catalysis in glucoside hydrolysis. Tetrahedron Lett. 1963; 14: 911-913.
28. Karkas JD and Chargaff E. Studies on the stability of simple derivatives of sialic acid. J. Biol. Chem. 1964; 239: 949-957.
29. Fife TH. General acid catalysis of acetal, ketal, and ortho ester hydrolysis. Acc. Chem. Res. 1972; 5: 264-272.
30. Manzi AE, Higa HH, Diaz S and Varki A. Intramolecular self-cleavage of polysialic acid. J. Biol. Chem. 1994; 269: 23617-23624.